Navigation Links
Investigational agent targets gene signaling pathways to improve response for patients with CLL
Date:12/8/2012

(ATLANTA, December 8, 2012) The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic lymphocytic leukemia (CLL), according to studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH).

CLL is a blood cancer that causes abnormal white blood cells called lymphocytes to accumulate in the blood, bone marrow, and in the lymph nodes or other organs, causing these organs to enlarge. Approximately 15,000 Americans are diagnosed with CLL every year; nearly 70 percent of those affected are 65 and older. , For some patients with slower growing disease, physicians employ "watch and wait" strategies to minimize unnecessary treatment. However, patients with high-risk features such as rapidly progressing disease require prompt treatment to manage symptoms and reduce organ damage.

Ibrutinib is a specialized anti-cancer therapy that targets the Bruton's tyrosine kinase (BTK, an enzyme important in the development of CLL). As an inhibitor of BTK, ibrutinib selectively targets leukemia cells, promoting their death and preventing them from growing while leaving normal cells unharmed. Studies suggest this design allows the drug to more effectively treat the disease, with encouraging early results in harder-to-treat patient groups such as elderly untreated patients and those whose disease has become resistant to other therapies or those who have experienced disease recurrence after receiving other therapies. Two studies will present efficacy and safety results testing the compound alone and in combination with other currently used therapies for CLL.

"The evidence collected to date on ibrutinib demonstrates that it may have the potential to improve long-term prognosis for patients who are not sensitive to standard treatment," said Claire E. Dearden, MD, moderator of the press conf
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
2. Rilpivirine for HIV: Added benefit for single agent proven
3. Travel Services (MyTSOnline) in Valencia Teams Up With Vendors to Become the Number One Travel Agent in the Santa Clarita Valley
4. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
5. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
6. Therapy combining exercise and neuroprotective agent shows promise for stroke victims
7. New substances 15,000 times more effective in destroying chemical warfare agents
8. Difficult to diagnose cases of infectious endocarditis solved with SPECT/CT imaging agent
9. Imaging agents predict breast cancer response to endocrine therapy
10. Pig stomach mucins are effective as anti-viral agents for consumer products
11. Method developed by VTT targets diagnosis of early Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... 2015 , ... Potomac Pilates, an elite Washington, D.C. metro area-based Pilates studio, ... ® by Potomac Pilates. On Thursday, July 30, Potomac Pilates will unveil its ... Potomac Pilates will continue to offer the same classes and personal experiences their clients ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... educators and service providers of children living with autism will converge upon Penn ... growing demographic. , The National Autism Conference will be held Aug. 3-6 ...
(Date:7/29/2015)... ... 29, 2015 , ... The NCCA re-accredited the Commission for ... 30, 2019, during its recent meeting. , The Commission received renewal of NCCA ... with the NCCA’s Standards for the Accreditation of Certification Programs. NCCA is ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the Miami Herald on ... and mental health disorders. Acu-detox may begin taking off in the South Florida community ... alcohol addiction. Although acupuncture is not a new practice, it is not widely used, ...
(Date:7/29/2015)... ... July 29, 2015 , ... Orthopedic surgeons at Lourdes Medical Center of ... Rotator Cuff System, a new implant to treat a common source of shoulder pain ... regeneration of additional tendon tissue, which could allow for faster healing and a decreased ...
Breaking Medicine News(10 mins):Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3
... Patients with idiopathic pulmonary fibrosis (IPF) are three times ... people without the disease, according to a recent study ... 1,000 patients with IPF and more than 3,500 matched ... people with IPF have roughly a three-fold increased risk ...
... Joe,s Sports & Outdoor stores,across the Pacific Northwest ... September for the Children,s Cancer Association (CCA). For the,third ... compassion and generosity by donating to CCA at checkout ... CCA Founder and CEO, Regina Ellis, said, "Once ...
... your smile goes farther than you think , , THURSDAY, Dec. ... -- and so can happy friends of your friends. , ... you and people you,ve never met can have an impact ... beyond people we,re directly connected to," said study co-author James ...
... MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ), today ... office in Westlake, Texas. The Company,s Germantown,facility ... including,MiddleBrook,s research and development group. The newly ... house up to 60 employees as MiddleBrook,grows. , ...
... standard dose of daunorubicin, study shows , , THURSDAY, Dec. ... chemotherapy drug daunorubicin prolonged survival for patients with previously ... study sponsored by the U.S. National Cancer Institute (NCI) ... and bone marrow. This study included 633 patients, aged ...
... on the eve of its 35th Anniversary, Ronald McDonald House Charities (RMHC) ... that a little help goes a long way. The initiative, designed to ... three core programs: Ronald McDonald House, Ronald McDonald Family Room and the ... ...
Cached Medicine News:Health News:Double threat: Deadly lung disease also linked to heart attacks 2Health News:Joe's Sports & Outdoor In-Store Promotion Raises $18,000 for the Children's Cancer Association 2Health News:Being Happy Affects Even Those You Don't Know 2Health News:Being Happy Affects Even Those You Don't Know 3Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 2Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 3Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 4Health News:Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients 2Health News: Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times 2Health News: Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times 3
(Date:7/29/2015)... , July 29, 2015 Alvarado ... 23, called the Alvarado Spine & Joint Institute. ... and rehabilitation, focusing on spinal surgery and joint ... patient care takes a patient experience-focused approach. For ... they feel comfortable in, rather than patient gowns. ...
(Date:7/29/2015)... --  Turing Pharmaceuticals AG announced today that ... its first Chief Communication Officer. In this ... internal and external communications and will provide counsel to ... to Founder and Chairman, Martin Shkreli , and ... "We are excited to have Craig join Turing and ...
(Date:7/29/2015)... , July 27, 2015 Research ... addition of the "Global Neurostimulation Devices Market ... The analysts forecast the global neurostimulation devices market ... the period 2014-2019. The report, Global ... on an in-depth market analysis with inputs from ...
Breaking Medicine Technology:The Alvarado Spine & Joint Institute Opens July 30 in San Diego 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 3Global Neurostimulation Devices Market 2015-2019 2
... 2007 /PRNewswire/ -- Alfacell,Corporation today announced that ... officer and corporate secretary, will,present an overview ... a.m. EDT on Thursday, July 12, 2007, ... Conference in New York. , The audio ...
... and NORTH BRUNSWICK, New Jersey, July 03, 2007,/PRNewswire-FirstCall/ ... announced today that J. Michael French, Rosetta Genomics,President, ... Conference on Tuesday, July 10, at 11:00 am ... , A live audio webcast of the presentation ...
Cached Medicine Technology:Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging,Growth Opportunities Conference 2Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference 2
... fingertip ratchet disengagement allowing smooth, ratchet-free grasping. ... state-of-the-art quality in an instrument of extremely ... Low profile cutting tips allow access to ... instruments are available in just about every ...
... design provides fingertip ratchet disengagement allowing smooth, ... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ...
... patented ratchet design provides fingertip ratchet disengagement ... I Instrument program offers state-of-the-art quality in ... maintaining strength and durability. Low profile cutting ... joint spaces. Series I instruments are available ...
... A broad selection of procedurally ... capability and allow easy access to ... a variety of approaches.,Loop Handled Graspers ... that holds tissue firmly without tearing ...
Medicine Products: